Pearl River Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,273
Closed -$252K 508
2023
Q2
$252K Sell
3,273
-40,762
-93% -$3.16M 0.04% 420
2023
Q1
$3.31M Buy
44,035
+14,265
+48% +$1.06M 0.53% 48
2022
Q4
$2.35M Buy
29,770
+15,005
+102% +$1.12M 0.4% 67
2022
Q3
$1.04M Buy
+14,765
New +$1.16M 0.19% 167
2022
Q2
Sell
-8,153
Closed -$618K 456
2022
Q1
$618K Buy
+8,153
New +$646K 0.17% 191
2021
Q3
Sell
-11,301
Closed -$919K 428
2021
Q2
$919K Sell
11,301
-27,610
-71% -$2.26M 0.25% 125
2021
Q1
$3.07M Buy
+38,911
New +$3.05M 0.98% 16
2020
Q4
Sell
-8,097
Closed -$625K 387
2020
Q3
$625K Buy
+8,097
New +$617K 0.26% 130
2019
Q1
Sell
-1,850
Closed -$110K 423
2018
Q4
$110K Buy
+1,850
New +$116K 0.51% 42

Other funds holding CL

Pearl River Capital's CL Position: Q3 2023 in Review

Pearl River Capital sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 3,273 shares — an estimated $252K sold.

Pearl River Capital first reported a position in CL in Q4 2018 and held it in 9 quarters. The position peaked at $3.31M in Q1 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Pearl River Capital reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Pearl River Capital sold 3,273 Colgate-Palmolive shares in Q3 2023, an estimated $252K.
  • Pearl River Capital first reported a position in Colgate-Palmolive in Q4 2018 and held it in 9 quarters.
  • Pearl River Capital's Colgate-Palmolive position peaked at $3.31M in Q1 2023.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Pearl River Capital's 13F filing for Q3 2023, filed 13 Nov 2023.